Your browser doesn't support javascript.
loading
Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.
Amiot, Aurélien; Hulin, Anne; Belhassan, Mehdi; Andre, Chantal; Gagniere, Charlotte; Le Baleur, Yann; Farcet, Jean-Pierre; Delchier, Jean-Charles; Hüe, Sophie.
Afiliación
  • Amiot A; Department of Gastroenterology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; University of Paris Est Creteil, 94000 Créteil, France; LIC, Laboratoire d'Investigation Clinique EA 4393, 94000 Créteil, France. Electronic address: aurelien.amiot@hmn.aphp.fr.
  • Hulin A; University of Paris Est Creteil, 94000 Créteil, France; Laboratory of Pharmacology-Toxicology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; Laboratory of Biological Immunology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France.
  • Belhassan M; Department of Gastroenterology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; University of Paris Est Creteil, 94000 Créteil, France.
  • Andre C; University of Paris Est Creteil, 94000 Créteil, France; Laboratory of Biological Immunology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; INSERM, Unit U-955, IMRB, 94000 Créteil, France.
  • Gagniere C; Department of Gastroenterology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; University of Paris Est Creteil, 94000 Créteil, France.
  • Le Baleur Y; Department of Gastroenterology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; University of Paris Est Creteil, 94000 Créteil, France.
  • Farcet JP; University of Paris Est Creteil, 94000 Créteil, France; Laboratory of Biological Immunology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; INSERM, Unit U-955, IMRB, 94000 Créteil, France.
  • Delchier JC; Department of Gastroenterology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; University of Paris Est Creteil, 94000 Créteil, France.
  • Hüe S; University of Paris Est Creteil, 94000 Créteil, France; Laboratory of Biological Immunology, Henri-Mondor Hospital, DHU VIC, AP-HP, 94000 Créteil, France; INSERM, Unit U-955, IMRB, 94000 Créteil, France.
Clin Res Hepatol Gastroenterol ; 40(1): 90-8, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26138132
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Enfermedades Inflamatorias del Intestino / Monitoreo de Drogas / Infliximab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Clin Res Hepatol Gastroenterol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Gastrointestinales / Enfermedades Inflamatorias del Intestino / Monitoreo de Drogas / Infliximab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Clin Res Hepatol Gastroenterol Año: 2016 Tipo del documento: Article